Welcome to
On Feet Nation
Emcure Pharmaceuticals, one of the leading pharma companies in India, has filed papers with markets regulator SEBI to raise funds via an initial public offer (IPO). It will list the shares on NSE and BSE.
The company is looking to raise up to Rs 4,500-5,000 crore in an offer that would consist of a fresh issue of shares and an offer for sale (OFS). The fresh issue is likely to be worth Rs 1,100 crore whereas the offer for sale would be worth Rs 3,400 crore. Promoters and private equity investors are looking to offload their shares via the IPO.
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation